Q1 2025 · 13F-HR
NVP Associates, LLCholdings as filed
Filed 2025-05-12 · accession 0001415889-25-012671
$112.2M
Reported value
6
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 23834J201 | DAVE | DAVE INC | $48.2M | 42.9% | 582,675 | Common | SOLE |
| 87427V103 | TALK | TALKSPACE INC | $25.1M | 22.4% | 9,802,972 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $15.8M | 14.1% | 2,136,335 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $14.5M | 12.9% | 1,838,482 | Common | SOLE |
| 39957D201 | GROV | GROVE COLLABORATIVE HOLD INC | $4.4M | 3.88% | 3,225,097 | Common | SOLE |
| 683712103 | OPEN | OPENDOOR TECHNOLOGIES INC | $4.3M | 3.81% | 4,189,562 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.